← Back to daily list

RCEL · AVITA Medical, Inc.

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.

Cap structure and valuation

Cap structure
SP$4.34
SO30.8M
Options5.0M
Warrants0.4M
FD SO36.2M
MC$157.2M
Cash$8.3M
Total debt$46.1M
EV$195.0M
TTM Multiples
EV / Revenue2.7x
EV / EBITDA
MC / Net Income
EV / FCF
MC / FCF
Ownership & coverage
Institutional17.2%
Insiders1.5%
# Institutions104
Analysts2
ConsensusBuy
Avg target$9.02
Short % float8.3%
Days to cover7.70

MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-05-11. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative, or when fewer than four quarters are reported — a partial sum is not a trailing twelve months. Ownership & coverage per Yahoo Finance as of 2026-07-13 — institutional % is 13F-based, so it can lag a quarter and exceed 100% on share-count timing. Short interest per FINRA bi-monthly reporting, as of 2026-06-29; the float denominator can be unreliable on tiny floats.

Debt figure uncertain — $16.6M of liabilities are neither recognized debt nor a named non-debt item. Verify against the filing before relying on EV.

Financial statements

LTM12/31/2512/31/2412/31/2312/31/22
Total Revenue 72.3571.6164.2550.1434.42
Revenue YoY % 1.0%11.5%28.1%45.7%
Cost of Revenue 13.4812.799.097.786.04
Gross Profit 58.8658.8255.1642.3628.38
Gross Profit YoY % 0.1%6.6%30.2%49.3%
Gross Margin % 81.4%82.1%85.8%84.5%82.4%
SG&A 78.1980.5191.3965.6245.24
R&D 20.1820.8420.3620.8213.86
Operating Expense 98.38101.35111.7585.0255.88
Operating Income (39.51)(42.53)(56.59)(42.66)(27.50)
Operating Income YoY % 7.1%24.8%(32.7%)(55.1%)
Operating Margin % (54.6%)(59.4%)(88.1%)(85.1%)(79.9%)
EBITDA (37.06)(40.19)(55.47)(42.02)(26.94)
EBITDA Margin % (51.2%)(56.1%)(86.3%)(83.8%)(78.3%)
Interest Expense 5.195.005.361.140.02
Other Income / (Expense) (0.64)(1.04)8.480.89
Pretax Income (45.35)(48.58)(61.79)(35.31)(26.63)
Tax Provision (0.01)0.010.050.070.04
Net Income (45.34)(48.59)(61.84)(35.38)(26.66)
Net Margin % (62.7%)(67.8%)(96.3%)(70.6%)(77.5%)
Diluted EPS -$1.56-$1.74-$2.39-$1.40-$1.07
Basic EPS -$1.56-$1.74-$2.39-$1.40-$1.07
Diluted Avg Shares 30.527.925.925.325.0
Basic Avg Shares 30.527.925.925.325.0

Insider activity (last 2 years)

Date Filed Reporter Relationship Trans. Date Code Shares Price Total Value
2026-06-03 Woody Joseph Fralin Director 2026-06-02 P 5,000 $4.18 $20,901
2026-06-03 Woody Joseph Fralin Director 2026-06-02 P 5,000 $4.21 $21,035
2026-06-03 Woody Joseph Fralin Director 2026-06-01 P 5,000 $4.34 $21,700
2026-06-03 Woody Joseph Fralin Director 2026-06-01 P 5,000 $4.26 $21,300
2026-06-01 O'Toole David D Officer (CFO) 2026-05-29 A 5,000 $3.05 $15,258
2026-06-01 Vance Cary Guy Director, Officer (President and CEO) 2026-05-29 A 5,000 $3.05 $15,258
2026-05-20 O'Toole David D Officer (CFO) 2026-05-20 P 2,000 $4.26 $8,520
2026-05-19 O'Toole David D Officer (CFO) 2026-05-19 P 2,000 $4.24 $8,480
2026-03-11 O'Toole David D Officer (CFO) 2026-03-11 P 1,800 $4.78 $8,604
2026-02-23 O'Toole David D Officer (CFO) 2026-02-19 P 3,000 $4.15 $12,450
2026-02-19 O'Toole David D Officer (CFO) 2026-02-18 A 105,470 $0
2026-02-19 O'Toole David D Officer (CFO) 2026-02-18 A 155,510 $0
2026-02-19 KELSEY NICOLE Officer (Chief Legal Officer) 2026-02-18 A 98,390 $0
2026-02-19 KELSEY NICOLE Officer (Chief Legal Officer) 2026-02-18 A 145,060 $0
2025-08-29 McNamara Robert Director 2025-08-28 P 10,000 $4.50 $45,000
2025-08-26 O'Toole David D Officer (CFO) 2025-08-26 P 2,000 $4.52 $9,040
2025-08-20 McNamara Robert Director 2025-08-19 P 10,000 $5.00 $50,000
2025-08-12 O'Toole David D Officer (CFO) 2025-08-12 P 2,000 $4.81 $9,620
2025-06-05 Vance Cary Guy Director 2025-01-21 A 10,022 $0
2025-06-05 Vance Cary Guy Director 2025-01-21 A 4,295 $0
2025-06-05 REED JAN STERN Director 2025-01-21 A 10,022 $0
2025-06-05 REED JAN STERN Director 2025-01-21 A 4,295 $0
2025-06-05 McNamara Robert Director 2025-01-21 A 10,022 $0
2025-06-05 McNamara Robert Director 2025-01-21 A 4,295 $0
2025-06-05 COOK JEREMY CURNOCK Director 2025-01-21 A 10,022 $0
2025-06-05 COOK JEREMY CURNOCK Director 2025-01-21 A 4,295 $0
2025-06-05 Crowe Suzanne Director 2025-01-21 A 10,022 $0
2025-06-05 Crowe Suzanne Director 2025-01-21 A 4,295 $0
2025-06-05 Panaccio Lou Director 2025-01-21 A 10,022 $0
2025-06-05 Panaccio Lou Director 2025-01-21 A 4,295 $0
2025-06-05 CORBETT JAMES Director, Officer (CEO) 2025-01-21 A 520,000 $0
2025-06-02 O'Toole David D Officer (CFO) 2025-05-30 A 1,923 $4.78 $9,186
2025-03-10 McNamara Robert Director 2025-03-06 P 11,000 $8.30 $91,300
2025-02-20 McNamara Robert Director 2025-02-20 P 10,000 $10.09 $100,900
2025-02-20 O'Toole David D Officer (CFO) 2025-02-20 P 1,000 $9.90 $9,900
2025-02-19 O'Toole David D Officer (CFO) 2025-02-19 P 1,000 $10.25 $10,250
2025-01-29 Crowe Suzanne Director 2024-12-09 P 486 $13.15 $6,391
2025-01-22 O'Toole David D Officer (CFO) 2025-01-21 A 150,000 $0
2025-01-22 KELSEY NICOLE Officer (Chief Legal Officer) 2025-01-21 A 65,000 $0
2024-12-05 O'Toole David D Officer (CFO) 2024-12-05 P 475 $12.53 $5,952
2024-12-05 O'Toole David D Officer (CFO) 2024-12-05 P 500 $12.40 $6,200
2024-12-05 O'Toole David D Officer (CFO) 2024-11-29 A 785 $7.83 $6,147
2024-08-20 McNamara Robert Director 2024-08-19 A 10,000 $9.00 $90,000
2024-06-06 Panaccio Lou Director 2024-06-05 A 9,200 $0
2024-06-06 Panaccio Lou Director 2024-06-05 A 3,943 $0
2024-06-06 Crowe Suzanne Director 2024-06-05 A 9,200 $0
2024-06-06 Crowe Suzanne Director 2024-06-05 A 3,943 $0
2024-06-06 COOK JEREMY CURNOCK Director 2024-06-05 A 9,200 $0
2024-06-06 COOK JEREMY CURNOCK Director 2024-06-05 A 3,943 $0
2024-06-06 REED JAN STERN Director 2024-06-05 A 9,200 $0
2024-06-06 REED JAN STERN Director 2024-06-05 A 3,943 $0
2024-06-06 McNamara Robert Director 2024-06-05 A 9,200 $0
2024-06-06 McNamara Robert Director 2024-06-05 A 3,943 $0
2024-06-06 Vance Cary Guy Director 2024-06-05 A 9,200 $0
2024-06-06 Vance Cary Guy Director 2024-06-05 A 3,943 $0
2024-06-06 CORBETT JAMES Director, Officer (CEO) 2024-06-05 A 350,000 $0